ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
96,399.12
-0.83%
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs Yen
156.445
0.00%
Brent Oil
72.72
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Castle Biosciences Inc (CSTL) 銘柄情報

Castle Biosciences Inc

Castle Biosciences Inc (CSTL)

NASDAQ
27.53
0.44
(1.62%)
終了 12月22日 6:00AM
15分遅延
27.5305
0.0005
(0.00%)
取引時間後: 9:59AM
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
27.53
買値
27.50
売値
45.00
出来高
382,571
26.58 日の範囲 27.99
16.965 52 週間の範囲 35.84
時価総額
771.041M
前日終値
27.09
始値
26.58
時刻
264
@
27.53
(priorref)
最終取引時間
財務取引量
US$ 10,325,510
VWAP
26.9898
平均取引量 (3 か月)
386,010
発行済株式数
28,007,301
配当利回り
-
PER
-13.41
1 株当たり利益 (EPS)
-2.05
歳入
219.79M
純利益
-57.47M

Castle Biosciences Inc について

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. 詳細を表示

セクター
Medical Laboratories
業界
Medical Laboratories
ウェブサイト
www.castlebiosciences.com
本社
Wilmington, Delaware, USA
設立
-
Castle Biosciences Inc is listed in the Medical Laboratories sector of the ナスダック市場 with ticker CSTL. The last closing price for Castle Biosciences was US$27.09. Over the last year, Castle Biosciences shares have traded in a share price range of US$ 16.965 to US$ 35.84.

Castle Biosciences currently has 28,007,301 shares in issue. The market capitalisation of Castle Biosciences is US$758.72 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -13.41.

CSTL 最新ニュース

その他のニュース

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on Dec. 13, 2024, the Compensation Committee of its...

2024年12月19日
Business Wire

Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma

This recently published meta-analysis encompasses 13 peer-reviewed publications involving thousands of patients and affirms the powerful risk stratification provided by DecisionDx-Melanoma and...

2024年12月12日
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月12日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月12日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月12日
Edgar (US Regulatory)

Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a...

2024年11月20日
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月20日
Edgar (US Regulatory)

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year

Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional Development Castle...

2024年11月19日
Business Wire

Form 144 - Report of proposed sale of securities

2024年11月15日
Edgar (US Regulatory)

Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual Meeting

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new data highlighting the clinical performance of its...

2024年11月8日
Business Wire
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.58-5.427688079729.1129.7226.326375127.85698076CS
4-1.71-5.8481532147729.2432.626.331125329.93481284CS
12-0.44-1.5731140507727.9735.8426.338601031.17349753CS
265.4324.570135746622.135.8416.96539889427.73205612CS
526.5731.345419847320.9635.8416.96532137025.66441897CS
156-13.28-32.541043861840.8148.49.260131472223.36580206CS
2600.331.2132352941227.2107.699.260127733833.73190566CS

CSTL - Frequently Asked Questions (FAQ)

What is the current Castle Biosciences share price?
The current share price of Castle Biosciences is US$ 27.53
How many Castle Biosciences shares are in issue?
Castle Biosciences has 28,007,301 shares in issue
What is the market cap of Castle Biosciences?
The market capitalisation of Castle Biosciences is USD 758.72M
What is the 1 year trading range for Castle Biosciences share price?
Castle Biosciences has traded in the range of US$ 16.965 to US$ 35.84 during the past year
What is the PE ratio of Castle Biosciences?
The price to earnings ratio of Castle Biosciences is -13.41
What is the cash to sales ratio of Castle Biosciences?
The cash to sales ratio of Castle Biosciences is 3.51
What is the reporting currency for Castle Biosciences?
Castle Biosciences reports financial results in USD
What is the latest annual turnover for Castle Biosciences?
The latest annual turnover of Castle Biosciences is USD 219.79M
What is the latest annual profit for Castle Biosciences?
The latest annual profit of Castle Biosciences is USD -57.47M
What is the registered address of Castle Biosciences?
The registered address for Castle Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Castle Biosciences website address?
The website address for Castle Biosciences is www.castlebiosciences.com
Which industry sector does Castle Biosciences operate in?
Castle Biosciences operates in the MEDICAL LABORATORIES sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.5M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.63M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.84M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
8.58M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
5.96M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

議論

フィード全体を表示

最近閲覧した銘柄

NASDAQ
CSTL
Castle Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有